Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Sernova Biotherapeutics Inc

Market Cap 54.76M 39.17M 33.76M 31.07M 29.15M 3.7B 55.31M 367M 143M 1.81B 147M 144M 6.27B P/E Ratio 2026 *
-4.83x
P/E Ratio 2027 * -3.63x
Enterprise Value 54.76M 39.17M 33.76M 31.07M 29.15M 3.7B 55.31M 367M 143M 1.81B 147M 144M 6.27B EV / Sales 2026 *
-
EV / Sales 2027 * 11x
Free-Float
86.83%
Yield 2026 *
-
Yield 2027 * -
1 day-6.45%
1 week-3.33%
Current month+3.57%
1 month-9.38%
3 months-14.71%
6 months+7.41%
Current year+11.54%
1 week 0.14
Extreme 0.14
0.16
1 month 0.14
Extreme 0.135
0.17
Current year 0.12
Extreme 0.125
0.2
1 year 0.12
Extreme 0.12
0.21
3 years 0.12
Extreme 0.12
1.1
5 years 0.12
Extreme 0.12
2.22
10 years 0.1
Extreme 0.095
2.87
Manager TitleAgeSince
Chief Executive Officer 58 11/08/2024
Director of Finance/CFO 60 10/10/2024
Investor Relations Contact - 10/10/2024
Director TitleAgeSince
Director/Board Member 60 18/04/2012
Director/Board Member - 23/04/2023
Director/Board Member - 31/08/2024
Date Insider Type Main position Quantity % Market Cap.
05-21Option

Chairman

360,000 0.1035%
05-21Option

Director

260,000 0.0748%
05-21Option

Director

260,000 0.0748%
Change 5-day change 1-year change 3-year change Capi.($)
-6.45%-3.33%-12.12%-83.52% 39.15M
-1.29%+2.36%-18.16%+4.39% 120B
-0.18%-0.70%+4.48%-9.59% 12.9B
+1.95%+5.90%+28.98%+91.38% 7.44B
-0.70%-5.33%-47.25%-70.68% 4.2B
+0.78%+4.91%+12.86%+34.26% 2.55B
-0.61%+9.37%-16.28%-15.40% 1.8B
-1.86%-7.48%+3.12%-12.69% 1.66B
-0.91%-11.60%+150.66%+119.28% 1.37B
Average -0.98%+0.88%+11.81%+6.38% 16.85B
Weighted average by Cap. -0.92%+1.80%-12.42%+6.49%

Financials

2026 *2027 *
Net sales - 5M 3.58M 3.08M 2.84M 2.66M 338M 5.05M 33.54M 13.1M 166M 13.42M 13.14M 573M
Net income -12.83M -9.18M -7.91M -7.28M -6.83M -867M -12.96M -86.05M -33.61M -425M -34.44M -33.71M -1.47B -19.77M -14.14M -12.19M -11.22M -10.53M -1.34B -19.97M -133M -51.81M -655M -53.08M -51.96M -2.27B
Net Debt - -
Logo Sernova Biotherapeutics Inc
Sernova Biotherapeutics Inc. is a Canada-based clinical-stage company, which is focused on developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cell-derived cell therapies to create bio-hybrid organs to treat chronic diseases. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.
Employees
8
Date Price Change Volume
12/06/26 0.1450 $ -6.45% 129,330
11/06/26 0.1550 $ +3.33% 207,625
10/06/26 0.1500 $ 0.00% 6,300
09/06/26 0.1500 $ 0.00% 46,335
08/06/26 0.1500 $ 0.00% 49,500
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1450CAD
Average target price
0.4500CAD
Spread / Average Target
+210.34%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!